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Ar ticle
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M yelin is a multilamellar sheath generated by specialized glia called Schwann cells (SCs) in the peripheral nervous system
(PNS), which serves to protect and insulate axons for rapid neuronal signaling. In zebrafish and rodent models, we identify
GPR56/ADGRG1 as a conserved regulator of PNS development and health. We demonstrate that, during SC development,
GPR56-dependent RhoA signaling promotes timely radial sorting of axons. In the mature PNS, GPR56 is localized to distinct
SC cytoplasmic domains, is required to establish proper myelin thickness, and facilitates organization of the myelin sheath.
Furthermore, we define plectin—a scaffolding protein previously linked to SC domain organization, myelin maintenance, and a
series of disorders termed “plectinopathies”—as a novel interacting partner of GPR56. Finally, we show that Gpr56 mutants
develop progressive neuropathy-like symptoms, suggesting an underlying mechanism for peripheral defects in some human
patients with GPR56 mutations. In sum, we define Gpr56 as a new regulator in the development and maintenance of peripheral
myelin.
INTRODUCTION
Myelin, the lipid-rich insulation that ensures rapid nerve
conduction velocity, is generated by specialized glial cells:
oligodendrocytes in the central nervous system (CNS)
and Schwann cells (SCs) in the peripheral nervous system
(PNS; Nave and Trapp, 2008). Disruption of the myelin
sheath in patients with peripheral neuropathies (e.g., Charcot-Marie-Tooth disease [CMT]) causes severe symptoms,
including pain and neuronal damage that can ultimately lead
to paralysis (Harel and Lupski, 2014). Proper myelination is
required for a high quality of life in humans, yet the molecular mechanisms governing myelinating glial cell development
and myelination are poorly understood.
Recent works from our laboratory and others have
identified the adhesion class of G protein-coupled receptors (aGPCRs) as key regulators of myelinating glial cell
development (Monk et al., 2009, 2011; Glenn and Talbot,
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2013; Mogha et al., 2013; Shin et al., 2013a; Liebscher et al.,
2014; Ackerman et al., 2015; Giera et al., 2015; Petersen et
al., 2015; Küffer et al., 2016; Salzman et al., 2016). aGPCRs
represent the second-largest class of GPCRs in humans, yet
remain largely understudied because of their genomic and
structural complexity (Hamann et al., 2015). In brief, mature aGPCRs exist at the cell membrane as bipartite receptors
consisting of an N-terminal fragment (NTF) facilitating adhesion and a C-terminal fragment (CTF) containing the seven-transmembrane pass signaling domain, and modulation of
NTF–CTF interactions is associated with receptor activation
(Hamann et al., 2015). Using a transcription activator-like
effector nuclease–induced mutant allele of the aGPCR
Gpr56/Adgrg1 in zebrafish (gpr56stl13/stl13), we previously
determined that Gpr56 regulates proliferation of oligodendrocyte precursor cells (Ackerman et al., 2015). Analysis of
published expression datasets revealed that Gpr56 is also robustly expressed in SCs (Miller et al., 2006;Weiss et al., 2016).
Given the importance of Gpr126 (a closely related aGPCR)
in regulating SC biology (Monk et al., 2009, 2011; Glenn
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RESULTS
GPR56 regulates SC radial sorting via
Gα12/13 and RhoA signaling
Radial sorting is the process by which immature SCs encompass bundles of naked axons and sort individual axonal
segments into a 1:1 SC/axon segment relationship. The timing of radial sorting is essential; when radial sorting is impaired, both myelination and peripheral nerve maturation are
delayed (Jessen and Mirsky, 2005; Feltri et al., 2016). Analysis of peripheral nerves from Gpr56 mouse mutants (Li et
al., 2008) revealed radial sorting delays by transmission EM
(TEM; Fig. 1). At postnatal day (P) 3 in Gpr56 mouse mutant sciatic nerves (SNs; n = 4 mutant mice), the number of
axons sorted 1:1 with SCs was significantly reduced relative
to WT (n = 3) and heterozygous (n = 3) siblings (Fig. 1 G;
P < 0.0002, one-way ANOVA). Additionally, we observed
abnormal cytoplasmic protrusions from sorting SCs (indic942

ative of disrupted cytoskeletal rearrangements, Fig. 1, I and
J), basal lamina trails reflecting aberrant SC process extension
and retraction during radial sorting (Fig. 1 K), along with
other myelin abnormalities in the SNs of Gpr56 mutant mice
(Fig. 1, L–N; P < 0.002, one-way ANOVA). Deficient SC
precursor proliferation can cause radial sorting delays (Feltri
et al., 2016), and GPR56 is a known regulator of cell division
(Wu et al., 2013; Bae et al., 2014; Ackerman et al., 2015; Giera
et al., 2015); thus, we first tested if Gpr56 mutant SCs were
less proliferative than WT. Interestingly, SC proliferation and
total number were unaffected in Gpr56 mouse mutant SNs, as
was overall peripheral (saphenous) nerve size (Fig. S1).Therefore, in contrast to its role in oligodendrocyte precursor cells,
Gpr56 is dispensable for SC proliferation.
These findings suggest that GPR56 does not regulate
radial sorting by affecting SC numbers. Given the cytoplasmic
defects observed on P3 (Fig. 1, I and J), we hypothesized that
GPR56 may function in controlling dynamics of immature
SC protrusions and/or adhesion to axonal membranes.To test
this, we used a modified Boyden chamber to mimic axon–SC
interactions during radial sorting (Poitelon et al., 2015). In
brief, purified rat SCs were seeded within the upper compartment of a Boyden chamber in which neuronal fragments
were suspended below to induce SC “pseudopod” (mimicking cytoplasmic protrusion) growth. Pseudopods were then
collected, processed, and analyzed by long-gradient nano
reversed-phase liquid chromatography–mass spectrometry
(LC-MS; Fig. 2, A and B; see Materials and methods for full
details). Indeed, we determined that GPR56 is highly enriched in SC pseudopods (Fig. 2 C and Dataset 1), supporting
the hypothesis that GPR56 autonomously regulates SC cytoplasmic protrusion dynamics during radial sorting.
In the nervous system, GPR56 primarily signals through
Gα12/13 and RhoA (Iguchi et al., 2008; Luo et al., 2011; Ackerman et al., 2015; Giera et al., 2015), and indeed, Gα13 (protein symbol GNA13) and RhoA signaling proteins are also
enriched in SC pseudopods (Fig. 2, C and D; and Dataset
1). Further, we found a significant reduction in the relative
concentration of active, GTP-bound RhoA in Gpr56 mutant
nerves relative to WT sibling nerves on P6. We also detected
a significant decrease in active, GTP-bound RhoA in heterozygous nerves relative to WT (Fig. 2 E, n = 12 nerves
per genotype across three replicates), consistent with the observation that Gpr56+/− animals exhibit some mutant phenotypes onP3 (Fig. 1 H; P < 0.039, one-way ANOVA). To
test whether GPR56 functions through Gα12/13 and RhoA to
promote radial sorting, we used standard genetic manipulations to either enhance (via inhibition of Gα12/13) or suppress
(via transient overexpression of constitutively active RhoA)
radial sorting defects in gpr56stl13/stl13 mutant zebrafish (Lin et
al., 2009; Ackerman et al., 2015). Strikingly, injection of antisense morpholinos that block translation of the three zebrafish transcripts encoding Gα12/13 (3MO) strongly enhanced
radial sorting defects in the posterior lateral line nerve (pLLn)
of gpr56stl13/stl13 mutants and induced radial sorting defects in
GPR56/ADGRG1 in peripheral nerve | Ackerman et al.
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and Talbot, 2013; Mogha et al., 2013; Liebscher et al., 2014;
Petersen et al., 2015; Küffer et al., 2016) and the established
role of GPR56 in oligodendrocyte precursor cells (Ackerman et al., 2015; Giera et al., 2015; Salzman et al., 2016), we
sought to determine if GPR56 also regulates myelinating glial
development in the PNS.
Here, we use zebrafish and rodent models to define the
role of Gpr56 in SC development and myelination. Whereas
loss of Gpr56 from the CNS results in hypomyelination because of a reduction in oligodendrocyte precursor cell proliferation and mature oligodendrocyte numbers, we find no
apparent defect in SC proliferation or overall SC number in
Gpr56 mutants. Instead, we demonstrate that GPR56 functions through RhoA in early SC development to regulate
proper radial sorting of axons by SCs and that disrupted radial
sorting in Gpr56 mutants likely results from altered cytoskeletal remodeling. Additionally, we find that loss of Gpr56 from
mature nerve results in multiple myelin structural abnormalities, including increased myelin thickness, aberrant myelin
domain organization, shortened internode length, and failed
myelin maintenance. Finally, we identify plectin as a novel
interacting partner of GPR56 in SCs. Plectin is a large cytoskeletal linker protein that causes multiple diseases (plectinopathies) when mutated in humans (Winter and Wiche, 2013).
The most common plectinopathy is epidermolysis bullosa
simplex with muscular dystrophy, a rare skin-blistering disorder that presents with late-onset muscular dystrophy, but
mutations in PLECTIN have also been linked to defects in
peripheral myelin ultrastructure (Bauer et al., 2001). We find
that plectin physically interacts with GPR56, that plectin levels are up-regulated in the absence of Gpr56 (as expected for a
receptor-ligand pair), and that Plectin mutant SCs phenocopy
Gpr56 mutant SCs, suggesting that these proteins function
together to regulate SC biology. Together, our studies define
GPR56 as a novel and evolutionarily conserved regulator of
peripheral nerve development and function with important
implications for human health and disease.

heterozygote and WT siblings in a dose-dependent manner (P
< 0.001, two-way ANOVA; Fig. 3, A–I and M). Conversely,
transient overexpression of synthetic mRNA encoding constitutively active RhoA (rhov14) completely suppressed radial
sorting defects in gpr56stl13/stl13 mutants, suggesting a positive
role for RhoA in radial sorting via Gpr56 signaling (control
WT vs. control gpr56stl13/stl13: P < 0.023, unpaired Student’s
t test; rhov14 injected WT vs. rhov14 injected gpr56stl13/stl13:
P < 0.58, unpaired Student’s t test; Phenol red: n = 3; WT:
n = 3 stl13+/−, n = 4 stl13−/−; +rhov14: n = 3 animals per
genotype; Fig. 3, J–L, O, and P). Total axon number was not
affected by experimental conditions throughout (Fig. 3, N
and Q–R). The importance of RhoA in maintenance of
cell–cell contact points has been established (Parsons et al.,
JEM Vol. 215, No. 3

2010), suggesting that sorting delays in Gpr56 mutants may
not result from impaired process extension but rather from an
inability of SCs to maintain secure contacts with target axons
during radial sorting. This hypothesis is consistent with the
aforementioned signs of SC process retraction observed in P3
mouse mutant SNs (Fig. 1 K).
Myelin domain organization is impaired in Gpr56 mutants
We’ve defined that GPR56 signaling through RhoA is required for timely radial sorting of axons during peripheral
nerve development. Although this phenotype did not persist
through adulthood (Fig. 4, A–D; n = 3 animals per genotype, P < 0.57, unpaired Student’s t test; Fig. S2, A–D), we
noted several other pronounced alterations in mature periph943
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Figure 1. GPR56 is required for efficient radial sorting. (A–F) TEM images of SN from (A and B) WT (n = 3), (C and D) Gpr56+/− (n = 3), and (E and F)
Gpr56−/− mice (n = 4) on P3. SC precursor nuclei (N) surrounding and within axon bundles in Gpr56−/− nerves. Higher magnification images: B, D, and F. Bars,
2 µm. (G) Quantification of axons sorted 1:1 with SCs (***, P < 0.0002, one-way ANOVA). (H) Quantification of the number of axons per unsorted bundle
(*, P < 0.04, one-way ANOVA). (I–M) TEM images of P3 SN Gpr56−/− (n = 4) animals. Bars: (I, J, L, and M) 1 µm; (I inset and K) 500 nm. (I) Large bundles
of unsorted axons surrounded by SC processes are observed in a Gpr56−/− SN. Some SCs also exhibited abnormal cytoplasmic protrusions (arrowhead).
Higher magnification of the boxed in region shown within the inset. In addition, (J, L, and M) myelin abnormalities (outfoldings) and (K) nearly naked axons
associated with SCs and partially surrounded by SC basal lamina (arrows) were often observed. (N) Quantification of the percent of axons with myelin
abnormalities revealed a significant increase in myelin defects in Gpr56−/− nerves compared with WT controls (**, P < 0.002, one-way ANOVA). (G, H, and
N) Error bars represent SEM.

eral nerve. First, we observed Remak bundle defects. Remak
bundles are groups of small caliber axons sorted and individually encompassed by a single nonmyelinating SC. In Gpr56
mutants, Remak bundle morphology was impaired, such that
interdigitation of SC processes between axons within a single bundle was incomplete (Fig. 4 E, P < 0.027, one-way
ANOVA). In addition, we noted several deviations in mature
myelin ultrastructure. Myelin thickness was significantly increased in Gpr56 mouse mutant SNs (Fig. 4 F; reflected in
lower mean G-ratio, ∼180 fibers analyzed from three animals per genotype, P < 0.002, one-way ANOVA), and we
noted myelin outfoldings commonly associated with hypermyelination (Fig. 4 B).
In the PNS, myelin internodes possess two primary
structural domains: Cajal bands (longitudinal channels of SC
cytoplasm) and appositions (where the outermost layer of my944

elin contacts the SC plasma membrane; Sherman and Brophy,
2005). Strikingly, we also observed defects in the suborganization of peripheral myelin into Cajal bands and appositions
in Gpr56 mouse mutant SCs (Fig. 4 G; 154 WT and 168
Gpr56−/− fibers from three animals per genotype, P < 0.002,
one-way ANOVA), as well as SC cytoplasmic abnormalities
in gpr56stl13/stl13 zebrafish mutant SCs (Fig. S2 B). The function of Cajal bands is poorly understood because few proteins
have been linked to Cajal band formation (Court et al., 2004,
2009; Sherman et al., 2012; Walko et al., 2013). Of these proteins, Periaxin has been best studied; Periaxin stabilizes SC
appositions, and Periaxin mutations cause neuropathy-like
phenotypes in mouse and CMT disease in humans (Guilbot
et al., 2001). Although Periaxin is well characterized for its
role in CMT, mutations in PLECTIN (a cytolinker protein
shown to regulate SC domain organization) are similarly asGPR56/ADGRG1 in peripheral nerve | Ackerman et al.

Downloaded from jem.rupress.org on March 14, 2018

Figure 2. GPR56 and interacting proteins are
enriched in pseudopods after induction by membranes of DRG neurons dependent on BDNF and
NT-3. (A) Schematic representation of the pseudopod assay. DRG were dissected from E15.5 rats.
Neurons were selected with BDNF and NT-3 growth
factors. After purification, neurons were collected and
homogenized. SCs were induced or not with neuronal
membrane suspension. Pseudopods (Ps) were isolated
from cell bodies (CBs), and both were analyzed by MS.
(B) Quantification by bicinchoninic acid assay of the
protein content of SC pseudopods and CBs after induction. Data are shown as mean ± SD; n (independent experiment) = 3. *, P < 0.05. (C) Distribution of
proteins enriched by neuronal membranes. The abscissa axis indicates relative polarization of a protein
between P and CB. The ordinate axis indicates relative enrichment of a protein by neuronal membranes
in comparison to noninduced condition. Both GPR56
and GNA13 are found enriched in SC Ps after neuronal
membranes induction. (D) Protein ontology analysis
of the pathways most enriched in SC Ps. RhoA signaling is enriched by neuronal membranes. For more
complete listings, see Dataset 1. Student’s t test (unpaired) was used to test for statistical significance.
(E) GTP-RhoA pull-down assay revealed a significant
decrease in the proportion of GTP-RhoA (active) to
total RhoA in Gpr56−/− and Gpr56+/− animals relative to WT controls on P6 (**, P < 0.01, unpaired Student’s t test; data are shown as mean ± SEM; n = 4
nerves from n = 2 animals per technical replicate; n =
3 technical replicates).

JEM Vol. 215, No. 3

945

Downloaded from jem.rupress.org on March 14, 2018

Figure 3. Gpr56 signals through Gα12/13
and RhoA to promote radial sorting. (A–I)
TEM images of the pLLn of WT, gpr56stl13/+, and
gpr56stl13/stl13 larvae injected with (A–C) phenol
red control (n = 6 animals per genotype), (D–F)
0.5 ng 3MOs targeting Gα12/13 signaling (3MO =
gna12-MO, gna13a-MO, and gna13b-MO; n =
6 WT, n = 5 gpr56stl13/+, and n = 5 gpr56stl13/stl13
animals examined), or (G–I) 1 ng 3MO (n =
3 animals per genotype). (J–L) In a separate
series of experiments, animals were injected
with constitutively active rhov14 (rhov14: n =
3 animals per genotype; control: n = 3 each
WT and gpr56stl13/+, n = 4 gpr56stl13/stl3). Sorted
axons are pseudocolored orange. Myelinated
axons are pseudocolored blue. (A–L) Bar, 1
µm. (M) Two-way ANOVA analysis revealed
a significant interaction between genotype
and treatment for 3MO experiments (****, P <
0.0001). Tukey’s multiple comparisons test was
also performed and found a significant reduction in the number of sorted axons between
control WT embryos and control heterozygous
(****, P < 0.0001) as well as control mutant
embryos (****, P < 0.0001). A significant decrease in sorted axon number was observed
between 0.5-ng 3MO-treated WT and -treated
heterozygous (***, P < 0.001) and -treated
mutant embryos (****, P < 0.0001). No significant comparisons were found in the 1-ng
3MO condition. (N) Total axon number is unaffected by genotype or treatment (two-way
ANOVA). (O) Quantification of the number
of axons sorted 1:1 in phenol red controls (P
< 0.03, unpaired Student’s t test) compared
with (P) rhov14-injected embryos (no significant differences). (Q and R) Total axon
number was unchanged by test condition
(unpaired Student’s t test). Data reflect two
independent experimental replicates. (M–R)
Error bars represent SEM.
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Figure 4. GPR56 regulates mature myelin ultrastructure and domain organization. (A and B) TEM images of WT (n = 3) and Gpr56 mutant mouse (n
= 3) SNs on P21. Bar, 2 µm. White arrow denotes myelin outfolding. Black arrowheads denote morphologically WT Remak bundles, which are incompletely
formed in Gpr56 mutants (B, white arrowhead/inset). The asterisk marks an axon with no appositions. (C–E) Quantification of (C) total number of myelinated axons (P < 0.45, one-way ANOVA), (D) overall axon number (P < 0.81, one-way ANOVA), and (E) percentage of bundles containing axons that are not
946
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sociated with myelin maintenance defects in mice and neuropathy-like symptoms in humans (Walko et al., 2013;Winter
and Wiche, 2013), demonstrating the importance of myelin
domain architecture for sustained PNS health in humans. Interestingly, analysis by immunohistochemistry (IHC) revealed
that in mature SNs, GPR56 is specifically localized to discrete
cytoplasmic domains on the abaxonal SC membrane (Fig. 4,
I–K) and, thus, poised to regulate Cajal band formation.

Gpr56 is required for SC myelin maintenance
Defective organization of the myelin sheath precedes neuropathy-like symptoms in all mutants (e.g., Periaxin, Drp2, and
Plectin) previously shown to have Cajal band defects (Court et
al., 2004; Sherman et al., 2012;Walko et al., 2013). Gpr56 mutant mice present with Cajal band/apposition phenotypes, as
well as Srebf1c-like hypermyelination and Remak SC defects
(Cermenati et al., 2015); thus, we hypothesized that Gpr56
mutants would develop neuropathy-like symptoms with age
as is observed in both Cajal band and Srebf1c mutants. Ultrastructural analyses of mouse SNs on P90, P180, and P300
(Fig. 5, A–I) revealed small yet significant increases in the percent of axons with abnormal myelin profiles in Gpr56 mutants and heterozygotes relative to WT siblings at each stage
(n = 3 animals minimum per genotype/time point). Myelin
abnormalities were composed of outfoldings and other defects: axon regeneration signatures (bands of Büngner), SCs
myelinating other myelinating and Remak SCs, extensive

fully sheathed in Gpr56 mutants and WT sibling nerves (*, P < 0.03, one-way ANOVA). Error bars represent SEM. (F) Plots of G-ratios in mutants and WT
controls (P < 0.002, one-way ANOVA). (G) TEM images of Gpr56−/− myelinated axons with 0, 1, 2, or 3 appositions. (H) Distribution of the percentage of
myelinated axons (mean ± SD) per apposition number in WT (white bars) and Gpr56−/− SNs (black bars, **, P < 0.002, one-way ANOVA). (I–K) IHC showing
GPR56 (green), DAPI (nuclear stain, blue), and MBP (marker of mature myelin) localization on P21 SNs. In WT SNs, GPR56 is detected in pockets (arrowheads)
outside of MBP-positive rings but absent from mature axons. (J) GPR56 stain alone. (K) MBP stain alone. Bar, 5 µm.
JEM Vol. 215, No. 3
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Altered expression of cytoskeletal genes in developing and
mature Gpr56 mutant nerves
GPR56 signals via RhoA to regulate radial sorting (Figs. 1,
2, and 3), but the downstream signaling pathway(s) through
which GPR56 regulates the development of mature myelin
are not known. To determine what signaling pathway(s) may
underlie the phenotypes observed in Gpr56 mutants during
SC maturation in contrast to early SC development (radial
sorting), we performed RNA sequencing (RNA-seq) on
RNA isolated from SNs of P21 and P3 mutants and WT controls, respectively (n = 3 per genotype on P21; n = 4 per genotype on P3; Fig. S3). Importantly, we observed a significant
decrease in the expression of Gpr56 at both developmental
time points (Fig. S3 F). In accordance with the hypothesis
that GPR56 normally functions in SC pseudopods to promote stable cell-cell contacts during radial sorting, and with
the abnormal SC cytoplasmic extensions observed in Gpr56
mutant SCs on P3 (Fig. 1, I and J), we observed a significant
increase in the expression of genes associated with dynamic
actin filaments in mutant SN harvested on P3 during active
radial sorting (Fig. S3 D). We also found a statistically significant enrichment (−log[p-value] <20) in gene ontology
(GO) processes associated with actin dynamics, including (a)
actin-myosin filament sliding, (b) actin-mediated cell contraction, (c) actin filament–based movement, and (d) actin
filament–based process using g:Profiler (Dataset 2).
Interestingly, we also observed significant changes in expression of genes related to the cytoskeleton on P21, when
Cajal band defects are pronounced in Gpr56 mutant nerves.
Although we detected no differential expression of genes relating to the actin cytoskeleton, the expression of genes that
promote microtubule assembly (Map2 and Ttll7) was significantly increased in mutant nerves relative to controls, whereas
expression of genes that promote microtubule disassembly
(e.g., Eml2) was significantly down-regulated (Fig. S3 E). We
also found a statistically significant enrichment (-log[p-value]
< 4) in the Cytoskeletal Remodeling GO pathway by g:Profiler (Dataset 2). The molecular mechanisms that guide Cajal
band formation are poorly understood; however, microtubule

disorganization is a common feature of other mutants that
lack Cajal bands (Court et al., 2004). These findings suggest
that precise microtubule organization is necessary for Cajal
band formation and represents an important area of future research into the development of these understudied domains.
In addition to changes in the expression of genes involved
in microtubule dynamics, we also observed a striking dysregulation of a cluster of genes that share the SREBP-1 binding
motif. Although we observed a modest increase in expression
of SREBP1 target genes on P3, by P21 we noted a significant decrease in the expression of genes that share the SRE
BP-1 motif. Loss of sterol regulatory element-binding factor1c (Srebf1c) results in increased peripheral myelin thickness, Remak bundle defects, and peripheral neuropathy-like
symptoms in mice (Cermenati et al., 2015). Finally, although
the authors did not formally examine the role of Srebf1c in
Cajal band formation, Srebf1c mutants did not present with
overt Cajal band defects based on published TEM images of
Srebf1c−/− peripheral nerve (Cermenati et al., 2015).
Our transcriptional profiling experiments (Fig. S3 and
Dataset 2), combined with our genetic and biochemical
analyses (Figs. 2 and 3) demonstrate that GPR56 signaling
through Gα12/13 and RhoA is required to modify the actin
skeleton for proper radial sorting during early SC development. These data further suggest that, during SC maturation,
Gpr56 signals through SREBP1 pathway to regulate lipid
biogenesis and Remak bundle biology and through an alternative mechanism to modify microtubule dynamics for
proper Cajal band assembly.

Gpr56 mutants display neuropathy-like symptoms with age
In addition to myelin loss, impaired Cajal band formation
in Periaxin mutants is associated with shortened internodes,
leading us to hypothesize that loss of Gpr56 would affect
internode length (Court et al., 2004). Teased nerve fiber
analysis revealed a significant reduction in internode length
on P6 (not depicted) and on P21 in Gpr56 mutant mice
(Fig. 7, A–C; P < 0.05, one-way ANOVA). Moreover, on
P180, Gpr56 mutants displayed a hindlimb clasping phenotype (Fig. 7, D and E), and both Gpr56+/− (n = 16 on P180,
n = 15 on P300) and Gpr56−/− mutants (n = 13 on P180,
n = 12 on P300) performed poorly relative to WT controls
(n = 11 on P180, n = 10 on P300) on the accelerated rotarod, indicative of impaired sensory-motor coordination
and reduced grip strength (Fig. 7 F, P < 0.001; Fig. 7 G, P
< 0.005; two-way ANOVA analysis). To test whether behavioral deficits observed in Gpr56 mutant and heterozygous
mice reflected a reduction in nerve function, we performed
electromyography (EMG) analyses in vivo and found a significant increase in EMG latency in Gpr56 mutants (n =
11) relative to controls (n = 5 WT, n = 12 Gpr56+/−) in
animals aged P200–P300 (Fig. 7 H; P < 0.001, one-way
ANOVA) with a corresponding reduction in response velocity (Fig. 7 I; P < 0.001, one-way ANOVA). See Fig. 7 J
for example traces. Interestingly, although we observed no
overt changes in Na+ channel structure by teased nerve analysis (Fig. 7, A and B), we detected a significant increase in
the expression of genes related to K+ channel activity on
P21 and a significant decrease in the expression of the Na+
channel clustering protein Ndrg4 (Fontenas et al., 2016) on
both P3 and P21 (Fig. S3, C and D). GPR56 is also localized
to sensory neurons (Fig. S4, M–O), and future work with
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cell type–specific knockout lines will be important for understanding the relative contributions of GPR56 in neurons
versus SCs to peripheral nerve function.
Plectin is a novel interacting partner of
Gpr56 in peripheral nerve
To further define how GPR56 regulates SC function, we
next sought to determine which protein(s) interact with
GPR56 to facilitate peripheral nerve development. We recently showed that cellular prion protein (Prnp/PrpC) is secreted from neurons and modulates GPR126 (an aGPCR
closely related to GPR56) signaling and SC function. We
used the previously published N-terminal flexible tail ([FT]
residues 23–120) of PrPC (Küffer et al., 2016), which can activate GPR126 signaling in vitro and in vivo, to test whether
PrPC can also activate Gpr56 signaling in vitro. We did not
observe any significant increase in GPR56 signaling either
through RhoA or through an SRE-mediated transcriptional
response to FT compared with application of collagen III,
a known ligand of GPR56 (Luo et al., 2011; Fig. 8, A and
B; P < 0.03, unpaired Student’s t test). FT activates Gpr126
signaling through cAMP; to test whether GPR56 may signal
through this alternative pathway in response to FT, we measured cAMP levels after FT addition to GPR126 or GPR56.
As previously shown, FT robustly stimulates cAMP signaling
through GPR126 (Küffer et al., 2016) but had no effect on
GPR56 (Fig. 8 C; P < 0.0027, unpaired Student’s t test).
We next used an unbiased mass-spectrometry screen to
determine what protein(s) physically interact with GPR56
(unpublished data). Interestingly, the top hit from this screen
was plectin, a large cytolinker protein known to interact
with and modulate cell surface signaling molecules through
its coordinate reorganization of the actin and intermediate
filament cytoskeletal networks (Winter and Wiche, 2013).
PLECTIN is also mutated in a series of human diseases
termed plectinopathies, including epidermolysis bullosa
simplex with muscular dystrophy, a skin blistering disorder
that also presents with neuropathy-like symptoms because
of degeneration of intramuscular myelinated nerves (Bauer
et al., 2001; Winter and Wiche, 2013). First, we verified that
GPR56 and plectin physically interact in WT P5 SNs (n = 8
nerves from four animals) by coimmunoprecipitation (co-IP;
Fig. 8 D). Interestingly, although we were able to detect
binding of plectin to the CTF of GPR56 (not depicted), we
observed robust binding of plectin to the extracellular NTF
of GPR56 as well. Although this result most likely reflects
binding of plectin to the larger GPR56 NTF-CTF complex,
plectin has been shown to be secreted to the extracellular
matrix in pathological contexts (Shin et al., 2013b). Future
work will therefore be required to test whether plectin is
secreted to serve as a direct activating ligand for GPR56.
We next tested whether loss of Gpr56 affects plectin
expression in P6 SNs and found a significant increase in
plectin levels in Gpr56 mutants (n = 7 replicates: 1 biological replicate = 2 pooled nerves from one animal) relative
GPR56/ADGRG1 in peripheral nerve | Ackerman et al.
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cytoplasmic extensions, minifascicle formation, myelin debris (Fig. 5, J–O), and disrupted Schmidt-Lanterman incisures (Fig. S4, A and B). In addition, we observed a significant
interaction between genotype and age with respect to myelin abnormalities (P < 0.0001, two-way ANOVA; Fig. 5 P),
indicating that these phenotypes worsen with time. Axon
number remained largely unchanged with age, suggesting
that loss of Gpr56 does not induce widespread neuronal loss
(Fig. 5, Q–S). Analysis of Gpr56 mouse mutant dorsal and
ventral spinal roots, composed of purely sensory and purely
motor neurons, respectively, revealed similar demyelinating
signatures (Fig. S4, C–L).
Given the importance of Gpr56 in the formation of
Cajal bands, structures that span the entire internode and
can reach nearly 1 mm in length in adult mice (Court et al.,
2004), we hypothesized that standard TEM analysis may underestimate myelin abnormalities in Gpr56 mutants. Indeed,
analysis of serial EM reconstructions of Gpr56 mouse mutant
SN on P90 revealed a cumulative average of 68 ± 10% axons
showing at least one myelin defect over 15 µm of internode,
compared with 15 ± 6% in WT controls (Fig. 6, Fig. S5, and
Videos 1, 2, 3, and 4).
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Figure 5. Gpr56 mutant mice show progressive accumulation of myelin abnormalities. (A–C) TEM images of SNs from
(A) WT (n = 3), (B) Gpr56+/− (n = 3), and (C) Gpr56−/− (n = 4) mice
on P90. (D–F) TEM images of SNs from (D) WT, (E) Gpr56+/−, and
(F) Gpr56−/− mice on P180 (n = 3 animals per genotype). (G–I) TEM
images of SNs from (G) WT, (H) Gpr56+/−, and (I) Gpr56−/− mice
on P300 (n = 3 animals per genotype). Red arrowheads denote
abnormal myelin profiles. Black arrows mark Schmidt-Lanterman
incisures. Black box highlights myelin debris observed by P300.
(A–I) Bar, 2 µm. (J–O) SC defects and pathologies observed in
Gpr56 heterozygous and mutant peripheral nerves included bands
of Büngner (J; bar, 500 nm), aberrant myelination of other SCs (K;
bar, 2 µm), abnormal cytoplasmic protrusions (L; bar, 500 nm),
myelinated Remak bundles (M; bar, 4 µm), minifascicles (N; bar, 2
µm), and myelin debris accumulation (O; bar, 2 µm). (P) Two-way
ANOVA analysis revealed a significant interaction between age
and genotype (****, P < 0.0001). Dunnett's multiple comparisons
test also showed significant increases in the percent of axons
with abnormal myelin profiles in Gpr56+/− and Gpr56−/− animals
compared with WT at each time point (****, P < 0.0001). (Q–S) No
significant differences between total myelinated axon number in
WT and Gpr56−/− (P90: P < 0.15; P180: P < 0.44; P300: P < 0.89),
nor between Gpr56+/− and Gpr56−/− (P90: P < 0.14; P180: P <
0.13; P300: P < 0.52) at any stage. Unpaired Student’s t test. (P–S)
Error bars represent SEM.

to WT (n = 8 replicates) and heterozygous (n = 5 replicates) siblings, as expected for a positive interacting partner
of GPR56 (Fig. 8 E; P < 0.001, unpaired Student’s t test).
Finally, plectin is strongly expressed in SCs and specifically
localized to Cajal bands, and SC-specific KO of Plectin disrupts myelin domain organization and causes neuropathy-like
symptoms with age (Walko et al., 2013). Thus, plectin is a
novel binding partner for GPR56, and the presence of phenocopy coupled with both physical and genetic interactions
(Fig. 8, D and E) strongly suggest that GPR56 and plectin
function together to promote SC function and long-term
health of peripheral nerves.
DISCUSSION
GPR56 in myelinating glial cell development
In the CNS, oligodendrocytes form the myelin sheath that
both protects and insulates axons for rapid action potential
propagation (Jessen and Mirsky, 2005). We previously defined
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GPR56 as a novel regulator of oligodendrocyte development
(Ackerman et al., 2015; Giera et al., 2015; Salzman et al., 2016).
In the CNS, GPR56 regulates the timing of the transition
between oligodendrocyte precursor cell proliferation and differentiation. In the absence of GPR56, oligodendrocyte precursor cells prematurely exit the cell cycle resulting in fewer
numbers of myelinating oligodendrocytes; however, the myelinating oligodendrocytes that are produced generate phenotypically normal myelin (Ackerman et al., 2015; Giera et al.,
2015). In the PNS, SCs ensure long-term health of peripheral axons (Jessen and Mirsky, 2005). In contrast to the role
of GPR56 in regulating the numbers of myelinating glia in
the CNS, GPR56 does not affect SC proliferation or overall
numbers. Instead, we observe novel and distinct functions of
GPR56 in SC development (radial sorting) and in SC myelination (thickness, organization, and maintenance), and our data
suggest defects in cytoskeletal dynamics as underlying causes
of both early and late functions of GPR56 in peripheral nerve.
GPR56/ADGRG1 in peripheral nerve | Ackerman et al.
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Figure 6. Gpr56 is required for myelin stability. (A–D) Serial scanning EM images (350, 100 nm apart) of WT and Gpr56−/− mouse SN on P90 (n = 3
animals per genotype) were acquired and reconstructed to generate the WT and Gpr56−/− models shown in A and C, respectively. Single sections taken from
multiple locations along the nerve (1–4) are shown below each model (dashed lines show approximate locations). The percentage of axons with abnormal
myelin profiles was calculated per section over a 15-µm distance for the WT (B) and Gpr56 mutant (D) reconstruction and is graphed to show the percentage
of abnormalities per section (green line), the average percentage of abnormalities over all sections (black line) and the cumulative percentage of abnormalities (percentage of axons that show at least one abnormality over 15 µm [blue line]).

RhoA-dependent regulation of radial sorting by GPR56
During early SC development, we find that GPR56 signaling
is required for timely sorting of axons. Many proteins have
been shown to function during radial sorting, including small
Rho-GTPases (Nodari et al., 2007; Pereira et al., 2009; Feltri
et al., 2016). RhoA is robustly expressed during radial sorting
(Taylor et al., 2003; Melendez-Vasquez et al., 2004; Nodari
et al., 2007) and specifically enriched in SC pseudopods. The
function of RhoA in SCs has not been thoroughly examined,
however, given the established role of the related Rho GTPase
Rac in radial sorting (Nodari et al., 2007; Pereira et al., 2009;
Feltri et al., 2016). Rac positively regulates the formation/
protrusion of lamellipodia-like structures from SCs, whereas
RhoA activation typically inhibits process extension (Pereira
et al., 2009). Indeed, up-regulation of Rho kinase (ROCK;
a major downstream effector of RhoA signaling) in ILK
JEM Vol. 215, No. 3

SC-specific KO mice results in severe radial sorting delays
because of impaired process extension (Pereira et al., 2009).
In contrast, we find that reduced RhoA signaling in Gpr56
mutants likewise impairs radial sorting, which can be restored
upon transient overexpression of constitutively active RhoA.
These results indicate that RhoA levels must be very
tightly regulated during SC development, because both increased signaling in ILK mutants impairs SC process extension, and decreased signaling in Gpr56 mutants delays radial
sorting theoretically through impaired SC adhesion to axonal
membranes. In accordance with this hypothesis, a previous
study demonstrated that inhibition of ROCK in vitro results
in aberrant actin fiber organization and reduced SC adhesion
because of loss of stress fibers (Melendez-Vasquez et al., 2004).
ROCK is a serine–threonine kinase that regulates actin organization through phosphorylation of proteins that modulate
951
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Figure 7. Gpr56 mutants display neuropathy-like symptoms. (A and B) IHC on teased nerve fibers from WT (n = 3) and Gpr56−/− (n = 4) mouse SNs on
P21 stained for Pan-NaV to mark nodes of Ranvier (arrowheads). Bar, 50 µm. (C) Quantification of internode length on P21 (P < 0.05, one-way ANOVA). (D
and E) Hindlimb clasping observed in Gpr56 mutants (n = 8/11) but not WT siblings on P180 (n = 1/11). (F and G) Quantification of time on rotarod to assess
sensorimotor control on P180 (genotype effect: ***, P < 0.001, two-way ANOVA; n = 11 WT, n = 16 Gpr56+/−, n = 13 Gpr56−/−) and P300 (genotype effect,
*, P < 0.02, two-way ANOVA; n = 10 WT, n = 15 Gpr56+/−, n = 12 Gpr56−/−). Error bars represent SEM. (H) Quantification of EMG latency (m/s) in animals
aged P200–P300 (***, P < 0.001, one-way ANOVA). Error bars represent SD. (I) Quantification of EMG response velocity (m/s) in animals aged P200–P300
(***, P < 0.001, one-way ANOVA). Error bars represent SD. (J) Representative traces from EMG recordings from WT (black, n = 5), Gpr56+/− (blue, n = 12), and
Gpr56−/− (red, n = 11) SNs. Arrows denote the point of the first positive deflection.
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Figure 8. Plectin and GPR56 physically and genetically interact in peripheral nerve. (A) GTP-RhoA assay to assess Gpr56 signaling in response
to exogenous ligands. Addition of collagen III, a known activating ligand of Gpr56, to HEK 293T cells coexpressing Gpr56 result in elevation of GTP-RhoA
levels over control (untransfected). Addition of prion protein (FT) does not induce Gpr56 signaling through RhoA. (B) Gpr56 Presto-Tango luciferase assay
to assess Gpr56 signaling in HTLA cells. Addition of collagen III results in a significant elevation of luciferase compared with AcOH alone control (*, P < 0.05,
unpaired Student’s t test). Addition of FT did not result in a significant elevation of luciferase relative to PBS controls (P = 0.0647, unpaired Student’s t test).
(C) cAMP ELISA assay to assess cAMP signaling through Gpr56 and Gpr126 (positive control) after addition of FT. Addition of FT to HEK 293T cells expressing
Gpr126 results in a significant elevation of cAMP (**, P < 0.01, unpaired Student’s t test) compared with PBS controls. Addition of FT to cells expressing
Gpr56 does not induce cAMP signaling (P = 0.4575, unpaired Student’s t test). (A–C) Data are representative of three biologically independent experiments.
Error bars represent SEM. (D) Co-IP to assess interactions between GPR56 and plectin in P5 WT SNs (n = 8 nerves from four animals per replicate; n = 3
replicates). Lane 1: plectin coimmunoprecipitates with GPR56 when the NTF of GPR56 fused to human IgG Fc (NTF-hFc) is used as a bait but not when
pulling down with hFc alone (lane 2). (E) Analysis of plectin levels in P6 SNs. Plectin is significantly increased in Gpr56−/− nerves over sibling controls (**, P <
0.002, unpaired Student’s t test, n = 12 nerves from six animals; error bars represent SEM). (F) Graphic model: Gpr56 promotes function of developing and
mature SCs. During early SC development, Gpr56 signals through Gα12/13 and RhoA to modulate the actin cytoskeleton for efficient radial sorting of axons.
During SC maturation/homeostasis, Gpr56 functions upstream of SREBP1 to regulate myelin thickness and Remak SC biology, potentially through SRE
signaling downstream of RhoA (gray dashed arrow). Concordantly, Gpr56 regulates mature myelin domain organization and myelin maintenance through
direct interactions with the cytolinker protein plectin, which has been shown to physically interact with additional regulators of myelin domain organization
(utrophin and β-dystroglycan). We therefore hypothesize that plectin serves as a docking center for cell signaling molecules that govern the partitioning of
myelin into mature subdomains (Cajal bands and appositions) and helps generate these structures through its interactions with the cytoskeleton.
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cytoskeletal dynamics (Amano et al., 1996). Myosin II light
chain is a direct target of ROCK, functions to stabilize and
increase the contractility of actin-myosin filaments (Tan et
al., 1992), and is required for ROCK-dependent reorganization of actin fibers in SCs (Melendez-Vasquez et al., 2004).
RNA-seq of Gpr56 mutant nerves during radial sorting (P3)
revealed a significant dysregulation of genes that modify the
actin and actomyosin cytoskeleton, including Myosin light
chain 1 (Myl1, also known as Mhc1/Mhc3), Myosin Light
Chain, Phosphorylatable, Fast Skeletal Muscle (Mylpf, also
known as Mlc2b), and Mybpc1, a myosin binding protein.
These findings support the hypothesis that GPR56 signals
through RhoA and ROCK to modify the actin and actomyosin cytoskeleton to establish firm SC-axon contacts during
radial sorting (Fig. 8 F, working model).
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Neuropathy-like symptoms in GPR56
mutants: links to human health
Several of the developmental defects observed in Gpr56 mutants (e.g., hypermyelination and reduced Cajal bands) are
known to precede disruptions in myelin integrity (Court
et al., 2004, 2009; Sherman et al., 2012; Walko et al., 2013;
Cermenati et al., 2015), and indeed, myelin maintenance
is also defective in Gpr56 mutants relative to controls. We
demonstrate that in Gpr56−/− mouse adults, impaired myelin stability coupled with shortened internode length results
in behavioral deficits consistent with the recorded EMG latency delay in Gpr56 mutants. Similar phenotypes are often
noted in mouse models of peripheral neuropathy and in
human neuropathy patients (Martini, 1999), suggesting that
mutations in GPR56 could cause neuropathy-like symptoms
in humans. Mutations in GPR56 cause several neurological
disorders affecting the CNS, including bilateral perisylvian
polymicrogyria (BPP or BPPR; OMIM #615752). BPP is a
cortical brain malformation resulting in severe neurological
impairments, including epilepsy and oromotor apraxia, and
a minority of BPP patients also present with arthrogryposis
multiplex congenital and exhibit EMG signatures consistent
with PNS pathology (Poduri et al., 2010). Our work defines
GPR56 as a novel, evolutionarily conserved regulator of SC
development and myelin maintenance and suggests a mechanism underlying PNS defects observed in BPP patients.
953
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Gpr56 regulates peripheral myelin
structure and maintenance
Although radial sorting recovers in Gpr56 mutants with time,
we show that loss of GPR56 leads to multiple defects in mature SCs. First, we observed a significant increase in myelin
thickness despite the delay in myelination onset. RNA-seq
analysis of mutant nerves on P21 (postradial sorting defects)
revealed a significant decrease in the expression of a cluster
of SREBP1 target genes. SREBP1 is a transcription factor
that regulates membrane lipid composition, and deletion of
the primary isoform of SREBP1 (Srebp1c) results in hypermyelination, incomplete separation of axons by Remak SCs,
and neuropathy-like symptoms with age (Cermenati et al.,
2015). Although the signaling pathways upstream of SREBP1
activity are poorly defined, analysis of the promoter region
of human and mouse SREBP1 revealed SRE binding sites
(Eberlé et al., 2004). GPR56-dependent RhoA signaling is
known to function upstream of SRE to regulate neural precursor migration (Iguchi et al., 2008), suggesting that GPR56
may also signal through this cascade to regulate SREBP1 expression and in turn, myelin thickness and Remak SC dynamics (Fig. 8 F, working model).
In addition to changes in myelin thickness and Remak
SC biology, we also observed a striking defect in mature myelin domain organization in Gpr56 mutants—a significant reduction in Cajal band number. Mature myelin is longitudinally
organized into two primary structural domains: Cajal bands
and appositions. Cajal bands are cytoplasmic channels separated from one another by regions of completely compact SC
membrane called appositions.The molecular mechanisms that
drive Cajal band development are poorly understood, in part
because few proteins have been linked to Cajal band development. Mutations in the large intracellular cytolinker protein
PLECTIN in humans are linked to peripheral nerve defects
(Winter and Wiche, 2013), and a recent study in mice defined plectin as a key regulator of myelin domain organization
(Walko et al., 2013). In SCs, plectin is specifically localized to
Cajal bands where it interacts with β-dystroglycan and utrophin to restructure vimentin intermediate filaments in the cy-

toskeleton (Walko et al., 2013). Interestingly, β-dystroglycan is
also a member of the Periaxin–DRP2–dystroglycan complex
that stabilizes appositions for proper formation of Cajal bands
(Sherman and Brophy, 2005). Here, we define plectin as a novel
interacting protein of GPR56: GPR56 and plectin physically
interact, and loss of Gpr56 results in up-regulation of plectin,
as expected if plectin mediates GPR56 downstream signaling.
Plectin has now been shown to interact with proteins
that are specifically enriched in Cajal bands (utrophin and
GPR56) as well β-dystroglycan, which is present in both
Cajal bands and in appositions as part of the Periaxin–DRP2–
dystroglycan complex. Furthermore, plectin is known to
function as a scaffold for receptors that mediate intracellular
signaling (Castañón et al., 2013). Together, these data suggest
that that in myelinating SCs, plectin could serve as a docking
center for both structural (Periaxin, DRP2, and utrophin) and
signaling (GPR56 and β-dystroglycan) molecules required
for efficient compartmentalization and long-term integrity
of the myelin sheath (Fig. 8 F, working model). Although the
downstream signaling pathways that promote peripheral myelin organization remain elusive, our RNA-seq analysis on
P21 (when changes in Cajal bands are present in Gpr56 mutant nerves) revealed significant dysregulation of genes that
regulate microtubule dynamics. Disorganization of the microtubule cytoskeleton is present in Periaxin mutants, which
also present with Cajal band defects (Court et al., 2004), supporting the hypothesis that reorganization of microtubules is
required for mature myelin domain assembly.

MATERIALS AND METHODS
Zebrafish
Stocks and rearing conditions.Zebrafish (Danio rerio) were
maintained in the Washington University Zebrafish Consortium facility. All experiments were performed in compliance
with Washington University's institutional animal care and
use committee. Embryos were collected from pairwise matings and reared at 28.5°C in egg water (5 mM NaCl,
0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4). Embryos and larvae were staged in days postfertilization (dpf) by
using morphological markers (Kimmel et al., 1995). The
gpr56stl13/stl13 line was genotyped as described previously
(Ackerman et al., 2015).

TEM. For zebrafish larvae, TEM was performed as described
(Czopka and Lyons, 2011) by using a PELCO BioWave Pro
with SteadyTempTM Digital Plus water-recirculating system.
Microwave-assisted fixation was used for all steps before Epon
treatment. In brief, embryos were fixed in modified Karnovsky’s fix (4% paraformaldehyde, 2% glutaraldehyde, and
0.1 M sodium cacodylate, pH 7.4) and left overnight at 4°C.
After fixation, embryos were postfixed in 2% osmium tetroxide in 0.1M sodium cacodylate and 0.1M imidazole, pH 7.4,
washed, and treated with saturated uranyl acetate. Embryos
were then dehydrated by using increasing concentrations of
ethanol followed by 100% acetone and then infiltrated overnight in an acetone-Epon mixture. Embryos were then transferred to 100% Epon, embedded in molds, and baked for at
least 48 h at 65°C. Fish were examined at approximately the
same body segment level to control for variability along the
anterior/posterior axis. For preparation of pLLns from
6-mo-old adult fish, we anesthetized animals in an ice-water
bath and severed the hindbrain before dissecting a portion of
the anterior pLLn, and fixation of adult tissue occurred as
described previously (Monk et al., 2009). In brief, adult tissues
were fixed via microwave-assisted fixation in modified Karnovsky’s fix as earlier in this paragraph and then postfixed in
2% osmium tetroxide in 0.1M sodium cacodylate, washed,
and dehydrated in increasing concentrations of ethanol followed by 100% propylene oxide. The tissues were then sub954

Mice
Lines and rearing conditions.All mouse (Mus musculus) experiments were performed in compliance with Washington
University's Institutional Animal Care and Use Committee as
well as the Animal Care and Use Committee at Boston Children’s Hospital. The Gpr56 knockout mice were obtained
pure on C57BL/6 (n = 11 generations) from the Mutant
Mouse Regional Resource Centers (032342-UCD), maintained on a C57BL/6 background, and genotyped as described previously (Li et al., 2008).
SC cultures and preparation of neuronal membranes.Primary rat SCs were prepared from SN on P3 as described
(Feltri et al., 1992). SCs were maintained in SC medium:
DMEM (Gibco), 1% FCS, 2 mM l-glutamine, 2 µM Forskolin (Calbiochem), and 2 ng/ml recombinant human NRG1-β
1 (R&D) and passaged not more than three times.
Neuronal membranes were prepared from dorsal root
ganglia (DRG) of rat embryos at 15 gestational days. In brief,
20 DRGs were plated on 9.5-cm2 dishes in C media: MEM
(Gibco), 10% FBS, 4 g l-1 d-glucose, 2 mM l-glutamine, 25
ng/ml BDNF (PeproTech), and 10 ng/ml NT-3 (PeproTech).
After 12 h, cells were switched for 2 wk in NB medium
(Gibco), 1X B27 supplement (Gibco), 4 g/l d-glucose, 2 mM
l-glutamine, 25 ng/ml BDNF (PeproTech), and 10 ng/ml
NT-3 (PeproTech). To obtain neuron-only cultures, the cells
GPR56/ADGRG1 in peripheral nerve | Ackerman et al.
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3MO and synthetic mRNA injection.3MOs targeting gna12,
gna13a, and gna13b (3MO) are previously published (Lin et
al., 2009; Ackerman et al., 2015) and were provided by F. Lin
(University of Iowa, Iowa City, IA). 3MOs were combined
and diluted in sterile water supplemented 1:10 with phenol
red dye and then injected at a final concentration of 0.5 ng
each in a total volume of 1 nl or 1 ng each in a total volume
of 2 nl. To control for adverse side effects from the injection
process, we also injected control siblings with an equal volume of phenol red diluted 1:10 in water (phenol red–injected
controls). Constitutively active Rho (rhov14) was provided by
L. Solnica-Krezel (Washington University, St. Louis, MO) and
was transcribed and injected as described previously (Lin et
al., 2009; Ackerman et al., 2015).

merged in a 2:1 mixture of propolyene oxide/EPON for 1 h,
followed by a 1:1 mixture overnight. The next day, the tissues
were transferred to 100% Epon before embedding and baking
at 65°C. Thin sections (70 nm) for all samples were mounted
on mesh grids and stained with 8% uranyl acetate followed by
Sato’s lead stain. We viewed sections on a Jeol (JEM-1400)
electron microscope, and images were acquired with an AMT
V601 digital camera. All images were processed and analyzed
by using ImageJ and Adobe Photoshop software. At 3 dpf,
quantifications were performed on the entire nerve. For
rhov14 transient overexpression experiments, we examined
five nerves from three WT, five nerves from three gpr56stl13/+,
and seven nerves from four gpr56stl13/stl13 larvae for phenol red
controls; and six nerves from three WT, six nerves from three
gpr56stl13/+, and five nerves from three gpr56stl13/stl13 larvae injected with 10 pg rhov14 synthetic mRNA. For 3MO experiments, we examined 10 nerves from 6 WT, 10 nerves from 6
gpr56stl13/+, and 9 nerves from 6 gpr56stl13/stl13 larvae for phenol red control treatment. For larvae treated with 0.5 ng
3MO, we examined 10 nerves from 6 WT, 8 nerves from 5
gpr56stl13/+, and 7 nerves from 5 gpr56stl13/stl13 animals. For larvae treated with 1 ng 3MO, we examined six nerves from
three WT, five nerves from three gpr56stl13/+, and six nerves
from n = 3 gpr56stl13/stl13 animals. For larval studies at 5 dpf, we
examined seven nerves from four WT and six nerves from
three gpr56stl13/stl13 animals. For adult studies, three nerves
from three individuals at 6 mo of age for WT and gpr56stl13/+,
and four nerves from three gpr56stl13/stl13 animals were analyzed.

were treated with FUDR (10 µM floxuridine and 10 µM
uridine) in NB medium for three cycles (2 d with FUDR,
2 d without FUDR). Neurons were collected by scraping
the network with forceps and homogenized in PBS with a
Dounce homogenizer. The homogenized solution was centrifuged at 300 g for 20 min to remove debris and collagen.
The supernatant was centrifuged at 30,000 g for 1 h. The
pellets were resuspended in DMEM (67 µl for each 9.5-cm2
dish) and stored at −80°C for 1 mo. To test their activity,
membranes were centrifuged onto serum-starved, rat primary
SCs, incubated at 37°C for an additional 20 min, lysed, and
analyzed by Western blotting for Akt activation.

Sample preparation for shotgun proteomics for SC pseudopod assay.Microporous filters with either pseudopods or cell
bodies were manually cut into tiny pieces and suspended in
200 µl of cold lysis buffer (50 mM Tris-FA, 150 mM NaCl,
0.5% sodium deoxycholate, 2% SDS, 2% IGEPAL CA-630
[Sigma-Aldrich], pH 8.0) supplemented with protease/phosphatase inhibitor cocktail tablets (Roche Applied Science).
The samples were sonicated until the liquid turned clear and
were then placed on ice for 30 min, followed by a 30-min
centrifugation at 20,000 g under 4°C. Supernatant from all
samples was carefully transferred to Eppendorf tubes, and protein concentrations were measured by bicinchoninic acid
assay kit (Pierce Biotechnology, Inc.).
For each extraction, 100 µg of protein was subjected to a
surfactant-aided precipitation/on-pellet digestion procedure
(An et al., 2015) to generate tryptic peptides for LC-MS analysis. Proteins first undergo reduction and alkylation by 3 mM
tris(2-carboxyl)phosphine and 20 mM iodoacetamide. Both
steps were performed under 37°C for 30 min in darkness,
with constant oscillation in an Eppendorf Thermomixer (Eppendorf). Proteins were then precipitated by addition of eight
volumes of chilled acetone, and the samples were incubated
under −20°C overnight. Precipitated proteins were collected
by centrifugation at 20,000 g under 4°C for 30 min, and
the supernatant portion was removed. This step allowed the
elimination of detergents and unwanted contaminants (e.g.,
phospholipids), which will compromise the analytical quality
of the LC-MS system. Protein pellets were rinsed with 500 µl
of chilled acetone/water mixture (85:15, vol/vol percentage),
JEM Vol. 215, No. 3

Long-gradient nano reversed-phase LC-MS for SC pseudopod assay.The nano RPLC system used in the present study
consists of a Spark Endurance autosampler (Emmen) and an
ultrahigh-pressure Eksigent Nano-2D Ultra capillary/nano
LC system. A nano LC/nanospray setup featuring
low-void-volume and high-chromatographic reproducibility
was used so that comprehensive separation of complex peptide samples could be achieved. Mobile phase A was 0.1%
formic acid in 2% acetonitrile, whereas mobile phase B was
0.1% formic acid in 88% acetonitrile. Peptides were first
loaded onto a large inner-diameter trap (300 µm inner diameter × 1 cm, packed with Zorbax 3M C18 material) with 1%
B at 10 µl min−1, and the trap was washed for 3 min before
bringing in line with the nano LC flow path. A series of optimized gradients (250 nl/min) was used to back-flush the
trapped peptides onto the nano LC column (75 µm inner
diameter × 100 cm, packed with Pepmap 3M C18 material),
which was heated homogenously to 52°C to improve chromatographic resolution and reproducibility. The 7-h gradient
profile used for extensive peptide separation was listed as follows: 3–8% B over 15 min, 8–24% B over 215 min, 24–38%
B over 115 min, 38–63% B over 55 min, 63–97% B in 5 min,
and finally isocratic at 97% B for 15 min.
An LTQ Oribtrap XL mass spectrometer (Thermo
Fisher Scientific) was used for peptide detection. Reproducibility of ionization efficiency was maintained via rinsing and conditioning of the nanospray needle (by dripping
50% methanol after every three runs). The instrument was
carefully calibrated for mass accuracy and Fourier transform
transmission. One complete scan cycle consisted of one MS1
survey scan (m/z 310−2,000) at a resolution of 60,000 and
seven subsequent MS2 scans by collision-induced dissociation
activation mode to fragment the top seven most-abundant
precursors in the survey scan. The automatic gain control target was set to 8 × 106, which allowed highly sensitive detection with little compromise to mass accuracy and resolution.
Dynamic exclusion was enabled with the following settings:
repeat count = 1, repeat duration = 30 s, exclusion list size =
500, and exclusion duration = 40 s. The activation time was
30 ms with an isolation width of 3 D for ion trap mass spectrometry; the normalized activation energy was 35%, and the
activation q was 0.25. All 20 samples were randomly analyzed.
Protein identification and quantification for SC pseudopod
assay. LC-MS.raw files were matched to a combined
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Pseudopod assay.Pseudopod assay was performed as described previously (Poitelon et al., 2015). In brief, starved SCs
were plated onto the upper compartment of the Boyden
chamber insert (3414; Corning). Cells were maintained in
DMEM, 2 mM l-glutamine and 0.5% BSA for 4 h at 37°C.
Then pseudopods were allowed to grow for 2 h at 37°C by
replacing bottom-chamber DMEM with neuronal membrane suspension. After induction, inserts were washed twice
in PBS, fixed with ice-cold methanol for 30 min on ice, and
washed again in PBS. For each filter, either the cell bodies on
the upper surface or the pseudopods on the undersurface
were removed with a cotton swab.

air-dried for 5 min, and resuspended in 80 µl Tris-FA.Trypsin
from porcine pancreas (Sigma-Aldrich) at a concentration of
0.25 µg/μl was added to the samples in two steps, at a final
enzyme/substrate ratio of 1:20 (wt/wt percentage). The samples were incubated under 37°C overnight (18–20 h) with
constant oscillation to achieve complete proteolytic cleavage.
The digestion step was terminated by addition of 1 µl formic
acid, after which the samples were centrifuged at 20,000 g
under 4°C for 30 min and transferred to LC vials.

Bioinformatics for SC pseudopod assay.The pathway and signaling networks were analyzed by using Ingenuity Pathways
Analysis software (Ingenuity Systems). Lists of proteins with
relative enrichment in pseudopods by neuronal membrane
were associated with canonical pathways in Ingenuity Pathways Analysis. The probability of association between the
dataset and the canonical pathway proteins was measured by
using Fisher’s exact test (Dataset 1). Networks of proteins
were algorithmically generated based on their connectivity.
956

RT-PCR.Standard RT-PCR was performed on cDNAs derived
from purified mouse DRG and purified rat SCs (gifts from Y.
Sasaki, J. Milbrandt laboratory,Washington University, St. Louis,
MO). For mouse Gpr56, the following primer pair was used to
amplify a 577-bp fragment that spans exons 5–10: 5′-CAG
TTACAGAGCCTGGAGTC-3′ and 5′-TGTGAGTGGCTT
CTACCTCT-3′. For rat Gpr56, the following primer pair was
used to amplify a 573-bp fragment that spans exons 9–12:
5′-GAGGGCTGTGAGACTGTTAG-3′ and 5′-TAGAGG
GGTAGATGACATGG-3′. The following primers were used
to amplify a 702-bp fragment from exons 3–6 of mouse and
exons 2–6 of rat Gapdh: 5′-GCCATCAACGACCCCTTC
ATT-3′ and 5′-CGCCTGCTTCACCACCTTCTT-3′.
TEM. For standard EM analyses, tissues were drop-fixed in
modified Karnovsky’s fix and processed as described previously (Monk et al., 2011). Semithin sections (200 nm) were
stained with toluidine blue and imaged with an AxioCam
MRm on a light microscope (Zeiss AxioImager M2). Thin
sections (70 nm) were treated as described for zebrafish analyses. For examination of dorsal and ventral roots, two roots
each were analyzed from two WT and three Gpr56−/− animals on P180.The number of animals examined at time point
for SN analyses is as follows: P3, six independent regions
(4,000×) of nerve from three WT, three Gpr56+/−, and four
Gpr56−/−; P14, four independent regions (2,000×) of nerve
from three WT, three Gpr56+/−, and three Gpr56−/−; P21, four
independent regions (2,000×) of nerve from three WT and
three Gpr56−/−; P90, three independent regions (2,000×) of
nerve from three WT, three Gpr56+/−, and four Gpr56−/−;
P180, three independent regions (2,000×) of nerve from
three WT, three Gpr56+/−, and three Gpr56−/−; and P300,
three independent regions (2,000×) of nerve from three WT,
three Gpr56+/−, and three Gpr56−/−.
For all experiments, myelinated fibers showing myelin outfoldings, infoldings, or demyelinating profiles
were considered abnormal.
Antibodies for IHC.We used the following primary antibodies: mouse anti–Gpr56-H11 (1:1,000; Jeong et al., 2012), rabbit anti–Ki67 (1:400; Abcam; Mogha et al., 2013), rabbit
anti–TUJ1 (1:1,000; Covance; Mogha et al., 2013), rat anti–
MBP (1:10; AbD Serotec; Mogha et al., 2013), and mouse
anti–pan sodium channel (IgG1, 1:400; Sigma-Aldrich; Saito
et al., 2003). Fluorescently conjugated secondary antibodies
were applied at a concentration of 1:1,000 (Invitrogen).
Rhodamine-phalloidin (1:100; Invitrogen;Terada et al., 2012)
was used for staining of Schmidt-Lanterman incisures.
IHC.For tissue sections, nerves were harvested and drop-fixed
in 4% paraformaldehyde overnight, transferred into 30% sucrose, and then embedded in optimal cutting temperature
compound. IHC was done as described previously on
7–10-µm-thick sections (Jeong et al., 2012). Stained sections
were imaged with an AxioCam MRm on a light microscope
GPR56/ADGRG1 in peripheral nerve | Ackerman et al.
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Swiss-Prot Mus musculus and Rattus norvegicus protein database because of the incomprehensiveness of the current rat
protein database. Files were matched by SEQUEST by using
a target-decoy search strategy, in which a concatenated protein database with both forward and reverse sequences was
used (Elias et al., 2005). The searching parameters include 15
ppm for precursor ion mass, 1.0 D tolerance for fragment ion
mass, 2 for maximal missed cleavages, carbamidomethylation
of cysteine as fixed modification, and oxidation of methionine as dynamic modification. Peptide inference, protein
grouping, and false-discovery rate control was accomplished
by Scaffold (v4.3.2; Proteome Software Inc.; Searle, 2010).
Corresponding parameters include for minimal peptide
length, 25 ppm for parent mass tolerance; 0.1 for DeltaCn;
2.1, 2.2, 2.6, 3.5 (pseudopods); and 1.1, 1.4, 1.7, 2.5 (cell bodies) for Xcorr thresholds for singly, doubly, triply, and
quadruply charged ions.
Chromatographic alignment and global intensity-based MS1 feature detection/extraction were accomplished by SIEVE (v2.1.377; Lopez et al., 2011). The major
steps we took are as follows. (a) Alignment of LC-MS
runs via the use of ChromAlign algorithm. The quality of LC-MS runs was monitored and benchmarked by
the alignment scores and base-peak ion current intensity
among all runs. (b) Determination of quantitative “frames”
based on m/z and retention time in the aligned collective dataset. The reliability of quantification was assured by
retaining only frames with high-quality area-under-thecurve data (e.g., signal/noise ratio >10). (c) Calculation
of peptide ion intensities for each frame. The resulting
.sdb files were incorporated with spectrum reports exported from Scaffold to associated MS2 fragmentation
scans with each frame by using customized R scripts. Another in-house-developed R package was used for the
normalization of ion current intensities for each protein
(by quantile ion intensities among individual runs) and the
aggregation of sun intensities from frame levels to protein
levels. The calculation of protein-abundance ratio, as well
as the evaluation of statistical significance with Student’s
t test (unpaired) between induced and noninduced (i.e.,
control) groups, was conducted to determine proteins with
significant changes in abundance. Detailed information
about the quantitative proteomics workflow is described
in several pieces of our previous works (Tu et al., 2014a,b;
An et al., 2015; Shen et al., 2015).

(Zeiss AxioImager M2), and analyses were performed in ImageJ software. SNs and DRG from three WT were used for
expression analyses. SNs from three WT and two Gpr56+/−
mice (controls) and three Gpr56−/− mice were used for quantification of cell proliferation on P3. For teased nerve
preparations, nerves were harvested and fixed for 30 min in
4% paraformaldehyde before teasing on glass slides. Samples
were then permeabilized for 15 min in acetone at −20°C
before antibody staining.

Morphometry.G-ratios were calculated from a total of ∼180
myelinated fibers per genotype (∼60 fibers each from three
mice per genotype) by taking the ratio of axon diameter to
fiber diameter. Measurements were obtained by using ImageJ
software. Internodal lengths were similarly measured from
IHC images in ImageJ software. For internode analyses, a total
of a total of 21 WT and 64 Gpr56−/− fibers were measured
per genotype on P21 (n = 3 mice per genotype). For apposiJEM Vol. 215, No. 3

Serial scanning EM and reconstruction.Nerves from P90
mice (three nerves from three WT and three Gpr56−/− animals) were harvested and drop-fixed in modified Karnovsky’s
fixative overnight. Nerves were then washed into 0.1 M sodium cacodylate before staining, embedding, and imaging at
Renovo Neural Inc. Approximately 400 serial sections were
imaged (100 nm each in thickness) per nerve, and data were
analyzed and reconstructed by using IMOD software (Kremer
et al., 1996).Videos depicting data and models from serial EM
analyses (Videos 1,2,3,and 4) were generated in ImageJ software.
Motor function.Motor function tests were performed in the
Animal Behavior Core Lab at Washington University School
of Medicine.The accelerated rotarod was used to assess sensorimotor function and grip strength and was performed on a
cohort of 11 WT, 16 Gpr56+/−, and 13 Gpr56−/− mice on
P180, and the same cohort was used for testing on P300 (n =
10 WT, n = 15 Gpr56+/−, and n = 12 Gpr56−/−) as described
previously (Idol et al., 2014).
Electrophysiology. Animals (WT, n = 5; Gpr56+/−, n = 12;
Gpr56−/−, n = 11) were anesthetized by using 4% isoflurane/96% oxygen (induction) and 2% isoflurane/98% oxygen
(maintenance) administered by inhalation. After preparation
of the sterile field, the right SN was isolated from the sciatic
notch to below the point of trifurcation, distal to the popliteal
artery. Cathodic, monophasic electrical impulses (duration =
50 μs, frequency = single, amplitude = 1 mA) were generated
by a single-channel isolated pulse stimulator (model 2100;
A-M Systems Inc.) and delivered to the SN proximal to the
implanted device via bipolar platinum/iridium microwire
electrodes (Medwire). Resulting EMGs were then differentially recorded in the tibialis anterior muscle by using intramuscular microwire electrodes (4 mil; California Fine Wire).
Measured signals were band-pass filtered (low pass = 1 Hz,
high pass = 5 kHz, notch = 60 Hz) and amplified (gain =
1,000–10,000×) by using a two-channel microelectrode AC
amplifier (model 1800; A-M Systems, Inc.) before being recorded on a desktop PC (Dell Computer Corp.) equipped
with a data acquisition board (DT3003/PGL; Data Translations). EMG traces were digitally recorded while peak latency
and maximal amplitude were calculated by using custom
Matlab software (The MathWorks, Inc.).
Western blot and GTP-Rho pull-down assay.For analysis of
RhoA activity in mouse nerves, P6 litters consisting of
Gpr56+/+, Gpr56+/−, and Gpr56−/− mice were used in
each of three separate experiments (we combined four
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RNA sequencing.Mouse SNs were harvested on P3 and P21
(n = 4 WT and n = 4 Gpr56−/− on P3; n = 3 WT and n = 3
Gpr56−/− on P21), flash frozen in liquid nitrogen, and stored
at −80°C. Total RNA was extracted by using an RNeasy
Mini kit (74104; Qiagen). First, nerves were allowed to thaw
on ice for at least 5 min in Buffer RLT containing
β-mercaptoethanol. During this time, small spring-loaded
surgical scissors were used to cut the nerves into smaller
pieces while the nerves were still in the liquid. Scissors were
cleaned with 100% ethanol between each sample. Once
thawed, nerves were homogenized by using a TissueRuptor
for ∼30–60 s followed by vortexing briefly, then passing the
sample through a syringe and successively smaller needles (22
gauge and then 28 gauge) at least 10 times each or until large
clumps of tissue were no longer visible. We then followed
manufacturer instructions for the RNeasy Mini kit to obtain
total RNA for each animal. RNA was eluted in 30 μl elution
buffer and then submitted on dry ice to the Genome Technology Access Center at Washington University in St. Louis,
MO, for processing and RNA-seq. Libraries were generated
by using Clontech Library Prep kits, and 12 samples were run
on a single lane of Illumina 3000, 1 × 50 bp. Approximately
20–40 million mapped reads were generated per sample. All
reads were mapped with STAR (Dobin et al., 2013).
R/Bioconductor was used for subsequent analysis.
Differential expression analysis was performed by using the
packages, DESeq (Anders and Huber, 2010), and edgeR
(Robinson et al., 2010) in R (http://www.R-project.org).
The original p-values were corrected via false-discovery rate
for multiple testing errors. In addition to a false-discovery
rate of <0.05, we considered genes differentially expressed
if the adjusted p-value was <0.05 and fold change >1.4×
(log2[fold change] >0.5). Individual P3 and P21 volcano plots
and comparison between the two developmental stages were
generated on normalized gene expression by using R. GO
analysis was performed with MetaCore and g:Profiler.

tion quantifications from electron micrographs, a total of 154
WT and 168 Gpr56−/− myelinated fibers were analyzed on
P21 (n = 3 mice per genotype). For analysis of
Schmidt-Lanterman incisures on P300, a total of 104 WT fibers and 93 Gpr56−/− fibers were analyzed (n
= 3 mice per genotype).

Gpr56 PRESTO-Tango assay.HTLA cells (a HEK293 cell line
stably expressing a tTA-dependent luciferase reporter and a
β-arrestin2-TEV fusion gene) were provided by the laboratory of B. Roth (University of Noth Carolina, Chapel Hill,
NC; Kroeze et al., 2015). Cells were plated in six-well plates
(500,000 cells/well) and transfected with either Gpr56 Tango
plasmid (Addgene) or as a control with pCDNA3 plasmid.
24 h posttransfection, cells were subjected to serum starvation
for further 24 h followed by treatment with human collagen
III (150 nM; CC054; Sigma-Aldrich) or full-length recombinant FT (res. 23–110, 10 µM), and as a control, with either
0.5 M acetic acid or PBS, respectively, overnight. Cells were
washed with PBS and processed with Bright-Glo luciferase
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system (E2610; Promega) according to manufacturer’s protocol. 200 µl of Bright-Glo solution, diluted in the assay buffer,
was added to 25 µg of cell lysate, and followed by 20 min of
incubation, luciferase activity was measured (as a function of
chemiluminescence). Data are representative of three biologically independent experiments.
cAMP assay.cAMP assay was done with a colorimetric
competitive immunoassay (Enzo Life Sciences) as described previously (Küffer et al., 2016). In brief, HEK
293T cells were transfected with either human GPR126
(cloned into pCDNA3.1/V5-His-TOPO vector) or
mouse Gpr56 (cloned into pCDNA3.1 vector) and 48 h
posttransfection were treated with either PBS or full-length
recombinant FT (10 µM) and then processed for quantification of cAMP. Data are representative of three biologically independent experiments.
Co-IP and immunoblotting.Co-IP and immunoblotting were
done as previously described (Luo et al., 2011). In brief, P5
mouse SNs (n = 8 nerves from four animals for each co-IP)
were lysed in RIPA buffer as described for the GTP-RhoA
pull-down assay. After extraction at 4°C with rocking, insoluble material was removed by centrifugation, and lysates were
precleared for 1 h at 4°C with protein G-Sepharose (101241;
Invitrogen). The lysate was equally divided into two; half of
the lysate was used for GPR56 IP, and the other half was used
for the control IP. Protein G beads were then used to
pull-down the GPR56NTF-hFc protein complex. Immunocomplexes were subjected to SDS-PAGE and Western blot by
using pan-plectin antibody (MAB5674; Sigma-Aldrich), and
rabbit anti–human IgG Fc antibody (31142; Thermo Fisher
Scientific) following standard protocols.
Plectin expression assay.P6 mouse SNs (n = 12 nerves from
six animals per genotype) were collected and lysed as described for the GTP-RhoA pull-down assay. Plectin levels
were assessed by Western blot by using a pan-plectin antibody
(MAB5674; Sigma-Aldrich). Two nerves were pooled from
each animal to make up a single replicate.
Statistical analyses
Analyses were performed blinded to genotype and treatment.
All data are presented as the mean ± SEM unless otherwise
noted. To represent significance, *, P < 0.05; **, P < 0.01;
***, P < 0.001; ****, P < 0.0001. A minimum of two technical replicates was performed for each described experiment.
Although we did not perform statistical tests to predetermine
sample size, our samples sizes are similar to previously published studies in the field. Statistical analyses were performed
by using one-way ANOVA, two-way ANOVA, or unpaired
Student’s t test with two tails with unequal variance when
required conditions were met. A departmental statistician
was consulted to confirm the appropriateness of each statistical analysis performed.
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nerves from the same genotype for one pull-down and did
three separate experiments, with a total of 12 for each genotype group). P6 SNs were dissected under a Leica stereo
microscope (MZ 6; Leica Pte Ltd.); four nerves from same
the genotype were combined in one group, powdered on
liquid nitrogen, then lysed in ice-cold RIPA buffer (1%
Nonidet P-40, 50 mM Tris, pH 7.6, 120 mM NaCl, and
1 mM EDTA) containing protease inhibitor cocktail set 1
(Calbiochem). The lysates were cleared of insoluble materials by centrifugation at 16,000 g for 10 min at 4°C. The
protein concentration was determined by a Bio-Rad protein assay method (Bio-Rad) according to the manufacturer's protocol, and equal amounts of protein were used for
each pull-down assay. The GTP-Rho pull-down assay was
performed as previously described (Luo et al., 2011). In
short, tissues were pulverized on liquid nitrogen, lysed in
300 µl of ice-cold RIPA buffer containing protease inhibitors with a cell disruptor for 10 min and homogenized with
a 26-gauge syringe needle. Equal amounts of total protein
were incubated with 60 µg GST-RBD beads (Cytoskeleton)
at 4°C for 90 min. The beads were washed twice with lysis
buffer and once with Tris-buffered saline buffer. Bound Rho
proteins were eluted by Laemmli sample buffer and detected
by Western blot by using mouse monoclonal anti–RhoA
antibody (ARH04, 1:1000; Cytoskeleton). For analysis of
GPR56-dependent RhoA signaling in vitro, HEK 293T
cells were plated in 6-well plates (500,000 cells/well) and
transfected with mouse Gpr56 (Luo et al., 2014) or not.
24 h posttransfection, cells were subjected to serum starvation for 36 h followed by treatment with human collagen III
(84 nM, CC054, positive control; Sigma-Aldrich) or
full-length recombinant FT (res. 23–110, 10 µM) and as a
control with either 0.5 M acetic acid or PBS, respectively,
for 5 min. Cells were lysed in lysis buffer (PBS + 1% Triton
X-100 + 1× protease inhibitors) followed by pull-down of
RhoA-GTP (Luo et al., 2011). We also blotted for GPR56
(ab172361, concentration of 1 µg/ml; Abcam) to assess the
success of transfection and actin (MAB1501, 200 ng/ml antibody and c concentration; Chemicon) for a loading control. Data are representative of three biologically
independent experiments.

Online supplemental material
Fig. S1 shows IHC analysis of cellular proliferation and the
total cell number in P3 mutant and control mouse SNs
as well as an assessment of overall saphenous nerve size
by toluidine blue staining, which can be affected by cell
number. Fig. S2 shows TEM images assessing pLLn integrity
and myelin ultrastructure in gpr56stl13/stl13 zebrafish mutants
during development and in adulthood to show conservation
with mouse phenotypes. Fig. S3 shows RNA-seq analysis of
the transcriptome of Gpr56 mutant and WT control nerves
on P3 and P21. Fig. S4 Shows further structural analysis
of Gpr56 mutant nerves: Schmidt Lanterman incisure
quantification by IHC, toluidine blue, and TEM images of
Gpr56−/− dorsal and ventral roots compared to control roots
on P180. Analysis of Gpr56 expression in neurons versus
SCs is shown. Fig. S5 shows additional TEM reconstructions
to supplement observations in Fig. 6. Video 1 shows serial
reconstruction of a myelinated fiber from a WT mouse SN
on P90 generated from 350 successive scanning EM images
(100 nm thick). Video 2 shows serial scanning EM images
(210 sections shown, 100 nm thick) from a WT mouse SN
on P90. Video 3 shows serial reconstruction of a myelinated
fiber from a Gpr56−/− mutant mouse SN on P90 generated
from 350 successive scanning EM images (100 nm thick).
Video 4 shows serial scanning EM images (210 sections
shown, 100 nm thick) from a Gpr56−/− mutant mouse SN
on P90. Dataset 1 is a summary of all proteins significantly
upregulated in SC pseudopods after induction and analysis of
the major cellular pathways found to be enriched. Dataset 2
is a summary of gProfiler results for significantly enriched or
depleted pathways in Gpr56 mutant nerves based on RNAseq analyses on P3 and P21. Raw data files can be accessed
from Zenodo (https://zenodo.org/record/1154250).
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Figure S1. SC proliferation, number, and nerve size are unaffected in Gpr56 mouse mutants. (A–D) IHC on P3 SNs from control (WT and Gpr56+/−,
n = 5) and Gpr56−/− (n = 3) animals with DAPI (blue) to mark all nuclei and Ki67 (red) to mark proliferating nuclei. Bar, 50 µm. (B and D) Ki67 stain alone.
(E) Quantification of the percentage of proliferating nuclei (Ki67+, white arrows) and (F) total number of nuclei revealed no significant difference between
control (WT and Gpr56+/−) and Gpr56−/− nerves. (E) P < 0.22, unpaired Student’s t test. (F) P < 0.63, unpaired Student’s t test. (G and H) Representative
toluidine blue stains of P3 saphenous nerve from (G) WT (n = 4) and Gpr56−/− (n = 4). (I) Quantification showed no significant difference in saphenous nerve
size (area) between WT and mutant (P < 0.64, one-way ANOVA). Bar, 40 µm. Error bars represent SEM.
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Figure S2. Gpr56 is required for proper myelin ultrastructure and maintenance in zebrafish. (A and B) TEM images of the pLLn from (A) WT (n = 4)
and (B) gpr56stl13/stl13 mutants (n = 3) at 5 dpf. Sorted axons are pseudocolored orange. Sorted and myelinated axons are pseudocolored blue. Bar, 1 µm. (B)
Abnormal pockets of SC cytoplasm surrounding mature myelin (pseudocolored red, black arrow) were observed in gpr56stl13/stl13 nerves and never observed
in WT control nerves. The myelinated axon demarcated by the arrow is shown magnified and without pseudocolor in B inset. In addition, myelin wraps
encompassing more than one axon (asterisks) were also observed in gpr56stl13/stl13 mutant nerves (n = 5/6 nerves from three of three animals) and never observed in WT (n = 0/7 nerves from four of four animals). (C) The total number of myelinated axons is unchanged in gpr56stl13/stl13 mutants by 5 dpf (P < 0.88,
unpaired Student’s t test), and (D) the total axon number remained unaffected (P < 0.89, unpaired Student’s t test). With age, gpr56stl13/stl13 mutant nerves
exhibit increased myelin defects. Error bars represent SEM. (E–H) TEM images of the pLLn from (E) WT, (F) gpr56stl13/+, and (G and H) gpr56stl13/stl13 zebrafish
(n = 3 animals per genotype) at 6 mo postfertilization (Mpf). Bar, 2 µm. (G and H) Nodes of Ranvier (black arrow) and minifascicles were also observed in
gpr56stl13/stl13 nerves but not in WT nerves. (I) Quantification of axon number in gpr56stl13/stl13 mutant nerves revealed a significant decrease in axon number
(*, P < 0.034) compared with WT controls. Unpaired Student’s t test was used to test for statistical significance. Error bars represent SEM.
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Figure S3. RNA-seq analysis of Gpr56 mutant peripheral nerves. (A and B) MA plots to show the distribution of expression between WT and mutant
samples on P3 and P21, respectively (n = 4 animals per genotype on P3; n = 3 animals per genotype on P21). (C) Dispersion plot to show how the data were
corrected before analysis to account for variability between replicates (n = 2 nerves from one animal per replicate). (D) Volcano plot to show differentially
expressed genes between Gpr56 mutant and WT control nerves on P3. Genes that encode modulators of the actin-myosin cytoskeleton are significantly
enriched in the mutant sample (right, underline). (E) Volcano plot to show differentially expressed genes between mutant and WT on P21. Differentially
regulated pathways included (1) extracellular matrix remodeling, (2) cytoskeletal transport/remodeling, and (3) potassium channel/transporter activity. (F)
Volcano plot to show genes with significant changes in gene expression on P3 alone (pink), genes that were differentially expressed on P21 alone (blue),
and shared differentially expressed genes (purple) on P3 and P21. Notably, SREBP1 target genes showed significant differential expression at both time
points (right). Ndrg4, a gene that is required for sodium channel clustering is significantly down-regulated at both time points. Importantly, Gpr56 was also
significantly down-regulated in mutant nerves at both stage.
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Figure S4. Gpr56−/− mouse dorsal and ventral spinal roots exhibit myelin defects. (A) IHC showing Phalloidin to mark Schmidt-Lanterman incisures
(red, white arrowheads), Pan-NaV (pan sodium channel to mark nodes of Ranvier, green), and DAPI (nuclear stain, blue) localization on teased nerve fibers
from WT (top) and Gpr56−/− mice on P300 (bottom, n = 3 animals per genotype). Bar, 100 µm. (B) Quantification of the number of Schmidt-Lanterman
incisures per 100 µm of internode revealed a significant decrease in the number of incisures present on mutant fibers compared with control fibers (*, P <
0.012). Unpaired Student’s t test was used to test for statistical significance. Error bars represent SEM. (C) Toluidine blue stain of semithin (200 nm) section
from WT dorsal root (n = 2 animals, two roots each examined) on P180. (D) TEM image from WT dorsal root on P180 (n = 2 animals, two roots each examined). (E) Toluidine blue stain of semithin (200 nm) section from Gpr56−/− dorsal root (n = 2 animals, two roots each examined) on P180. (F) TEM image
from Gpr56−/− dorsal root on P180 (n = 3 animals). Naked axons were present in all dorsal roots examined (red arrow). (G) Quantification of the percentage
of axons exhibiting myelin defects revealed a significant increase in Gpr56−/− dorsal roots (***, P < 0.001, one-way ANOVA) compared with WT controls. Error
bars represent SEM. (H) Toluidine blue stain of semithin (200 nm) section from WT ventral root on P180 (n = 2 animals, two roots each examined). (I) TEM
image from WT ventral root on P180 (n = 2 animals, two roots each examined). (J) Toluidine blue stain of semithin (200 nm) sections from Gpr56−/− ventral
root on P180 (n = 3 animals). Signs of demyelinated axons are present (red arrow). (K) TEM image from Gpr56−/− ventral root on P180 (n = 3 animals). Demyelinating axons engulfed by macrophages were evident (red arrow). (L) There was a significant increase in the percent of axons exhibiting myelin defects
in Gpr56−/− ventral roots (****, P < 5.38 × 10−10, one-way ANOVA) compared with WT controls. Error bars represent SEM. (M-P) GPR56 is expressed in DRG
neurons. (K and L) Bars: (Toluidine blue sections) 20 µm; (TEM sections) 4 µm. (M) RT-PCR showing expression of Gpr56 and Gapdh in purified mouse DRG
neurons compared with purified rat SCs. Data are representative of two technical replicates. (N–P) Representative IHC on P3 DRG showing colocalization
of GPR56 (green) with Tuj1 (red) in DRG neuron cell bodies (white arrowheads). DAPI, blue. GPR56 was not readily detected in Tuj1+ axons (white arrows).
Three DRGs from three animals assessed for GPR56 expression.
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Figure S5. Gpr56 is required for mature myelin stability. (A–H) Serial scanning EM images (350 images, 100 nm apart) of WT (A and C) and Gpr56−/− (E
and G) SNs on P90 (n = 3 animals per genotype) were acquired and reconstructed to generate the WT and Gpr56−/− models shown. Single sections taken
from multiple locations along the nerve (1–4) are placed below each model (approximate location denoted by white dashed line). The percentage of axons
with abnormal myelin profiles was calculated per section over a 15-µm distance for both WT (B and D) and Gpr56 mutant (F and H) reconstructions and
are graphed to show the percentage of abnormalities per section or field of view (green line), the average percentage of abnormalities given the percentage per section (black line), and the cumulative percentage of abnormalities or the percentage of axons that show at least one abnormality over the
15-µm distance (blue line).
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Video 1. Serial reconstruction of a myelinated fiber from a WT mouse SN on P90. The video shows construction of a WT
model (purple) from 350 successive scanning EM images (100 nm thick).

Video 2. Serial scanning EM images from a WT mouse SN on P90. The video shows 210 successive sections (100 nm thick)
with Schmidt-Lanterman incisures denoted by black arrows and nodes of Ranvier marked by red asterisks.

Video 3. Serial reconstruction of a myelinated fiber from Gpr56−/− mutant mouse SN on P90. This video shows the
construction of a Gpr56 mutant model (purple) from 350 successive scanning EM images (100 nm thick).

Video 4. Serial scanning EM images from a Gpr56−/− mutant mouse SN on P90. This video shows 210 successive sections
(100 nm thick) with Schmidt-Lanterman incisures denoted by black arrows and nodes of Ranvier marked by red asterisks.

Dataset 1 presents data about proteins enriched in pseudopods after induction by BDNF/NT-3 neuronal membranes. (A) 141
proteins were found to be more abundant in pseudopods (Ps/CB ratio >2.5) after induction by neuronal membranes (Ps induced/noninduced ratio >1.1). The subcellular localization of each protein was derived from the UniProt subcellular location.
(B) Complete protein ontology analysis of the significant canonical pathways in SC pseudopods. 38 pathways are increased
after neuronal membrane stimulation as compared with DMEM.
Dataset 2 presents data on MetaCore analysis to uncover differentially regulated pathways using gProfiler. (A–C) Significantly
down-regulated GO processes (A), molecular functions (B), and pathway maps (C) in P3 Gpr56 mutant nerves compared with
WT. (D–F) Significantly increased GO processes (D), molecular functions (E), and pathway maps (F) in P3 Gpr56 mutant nerves
compared with WT. (G–I) Significantly down-regulated GO processes (G), molecular functions (H), and pathway maps (I) in P21
Gpr56 mutant nerves compared with WT. (J–L) Significantly increased GO processes (J), molecular functions (K), and pathway
://
maps (L) in P21 Gpr56 mutant nerves compared with WT. Raw data files are freely accessible from Zenodo (https
zenodo.org/record/1154250).
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